BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 29483224)

  • 1. Adrenalectomy Lowers Incident Atrial Fibrillation in Primary Aldosteronism Patients at Long Term.
    Rossi GP; Maiolino G; Flego A; Belfiore A; Bernini G; Fabris B; Ferri C; Giacchetti G; Letizia C; Maccario M; Mallamaci F; Muiesan ML; Mannelli M; Negro A; Palumbo G; Parenti G; Rossi E; Mantero F;
    Hypertension; 2018 Apr; 71(4):585-591. PubMed ID: 29483224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of Different Treatment Strategies on New-Onset Atrial Fibrillation Among Patients With Primary Aldosteronism: A Nationwide Longitudinal Cohort-Based Study.
    Pan CT; Liao CW; Tsai CH; Chen ZW; Chen L; Hung CS; Liu YC; Lin PC; Chang CC; Chang YY; Wu VC; Lin YH;
    J Am Heart Assoc; 2020 Mar; 9(5):e013699. PubMed ID: 32070205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of Atrial Fibrillation and Mineralocorticoid Receptor Activity in Patients With Medically and Surgically Treated Primary Aldosteronism.
    Hundemer GL; Curhan GC; Yozamp N; Wang M; Vaidya A
    JAMA Cardiol; 2018 Aug; 3(8):768-774. PubMed ID: 30027227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atrial Fibrillation in Primary Aldosteronism.
    Pan CT; Tsai CH; Chen ZW; Chang YY; Wu VC; Hung CS; Lin YH;
    Horm Metab Res; 2020 Jun; 52(6):357-365. PubMed ID: 32289838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term control of arterial hypertension and regression of left ventricular hypertrophy with treatment of primary aldosteronism.
    Rossi GP; Cesari M; Cuspidi C; Maiolino G; Cicala MV; Bisogni V; Mantero F; Pessina AC
    Hypertension; 2013 Jul; 62(1):62-9. PubMed ID: 23648698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective appraisal of the prevalence of primary aldosteronism in hypertensive patients presenting with atrial flutter or fibrillation (PAPPHY Study): rationale and study design.
    Rossi GP; Seccia TM; Gallina V; Muiesan ML; Leoni L; Pengo M; Ragazzo F; Caielli P; Belfiore A; Bernini G; Cipollone F; Cottone S; Ferri C; Giacchetti G; Grassi G; Letizia C; Maccario M; Olivieri O; Palumbo G; Rizzoni D; Rossi E; Sechi L; Volpe M; Mantero F; Morganti A; Pessina AC
    J Hum Hypertens; 2013 Mar; 27(3):158-63. PubMed ID: 22718050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time-Dependent Risk of Atrial Fibrillation in Patients With Primary Aldosteronism After Medical or Surgical Treatment Initiation.
    Kim KJ; Hong N; Yu MH; Lee H; Lee S; Lim JS; Rhee Y
    Hypertension; 2021 Jun; 77(6):1964-1973. PubMed ID: 33866798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associated factors and effects of comorbid atrial fibrillation in hypertensive patients due to primary aldosteronism.
    Sakaguchi S; Okamoto R; Inoue C; Akao M; Kamemura K; Kurihara I; Takeda Y; Ohno Y; Inagaki N; Rakugi H; Katabami T; Tsuiki M; Tanabe A; Tamura K; Fujita S; Yano Y; Dohi K; ; Naruse M
    J Hum Hypertens; 2023 Sep; 37(9):757-766. PubMed ID: 36153382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary Aldosteronism: Practical Approach to Diagnosis and Management.
    Byrd JB; Turcu AF; Auchus RJ
    Circulation; 2018 Aug; 138(8):823-835. PubMed ID: 30359120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism.
    Catena C; Colussi G; Lapenna R; Nadalini E; Chiuch A; Gianfagna P; Sechi LA
    Hypertension; 2007 Nov; 50(5):911-8. PubMed ID: 17893375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular remodeling and duration of hypertension predict outcome of adrenalectomy in primary aldosteronism patients.
    Rossi GP; Bolognesi M; Rizzoni D; Seccia TM; Piva A; Porteri E; Tiberio GA; Giulini SM; Agabiti-Rosei E; Pessina AC
    Hypertension; 2008 May; 51(5):1366-71. PubMed ID: 18347224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiofrequency ablation compared with laparoscopic adrenalectomy for aldosterone-producing adenoma.
    Liu SY; Chu CM; Kong AP; Wong SK; Chiu PW; Chow FC; Ng EK
    Br J Surg; 2016 Oct; 103(11):1476-86. PubMed ID: 27511444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnosis and treatment outcome in primary aldosteronism based on a retrospective analysis of 187 cases].
    Szücs N; Gláz E; Varga I; Tóth M; Kiss R; Patócs A; Jakab C; Perner F; Járay J; Horányi J; Dabasi G; Molnár F; Major L; Füto L; Rácz K; Tulassay Z
    Orv Hetil; 2006 Jan; 147(2):51-9. PubMed ID: 16509213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atrial fibrillation in primary aldosteronism.
    Watson T; Karthikeyan VJ; Lip GY; Beevers DG
    J Renin Angiotensin Aldosterone Syst; 2009 Dec; 10(4):190-4. PubMed ID: 19617274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal Outcomes in Medically and Surgically Treated Primary Aldosteronism.
    Hundemer GL; Curhan GC; Yozamp N; Wang M; Vaidya A
    Hypertension; 2018 Sep; 72(3):658-666. PubMed ID: 29987110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcomes following unilateral adrenalectomy in patients with primary aldosteronism.
    Hannon MJ; Sze WC; Carpenter R; Parvanta L; Matson M; Sahdev A; Druce MR; Berney DM; Waterhouse M; Akker SA; Drake WM
    QJM; 2017 May; 110(5):277-281. PubMed ID: 28180906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study.
    Giacchetti G; Ronconi V; Turchi F; Agostinelli L; Mantero F; Rilli S; Boscaro M
    J Hypertens; 2007 Jan; 25(1):177-86. PubMed ID: 17143190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New-Onset Atrial Fibrillation in Patients With Primary Aldosteronism Receiving Different Treatment Strategies: Systematic Review and Pooled Analysis of Three Studies.
    Tsai CH; Chen YL; Pan CT; Lin YT; Lee PC; Chiu YW; Liao CW; Chen ZW; Chang CC; Chang YY; Hung CS; Lin YH
    Front Endocrinol (Lausanne); 2021; 12():646933. PubMed ID: 34108934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study.
    Hundemer GL; Curhan GC; Yozamp N; Wang M; Vaidya A
    Lancet Diabetes Endocrinol; 2018 Jan; 6(1):51-59. PubMed ID: 29129576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal damage in primary aldosteronism: results of the PAPY Study.
    Rossi GP; Bernini G; Desideri G; Fabris B; Ferri C; Giacchetti G; Letizia C; Maccario M; Mannelli M; Matterello MJ; Montemurro D; Palumbo G; Rizzoni D; Rossi E; Pessina AC; Mantero F;
    Hypertension; 2006 Aug; 48(2):232-8. PubMed ID: 16801482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.